3P Biopharmaceuticals' Grant

3P Biopharmaceuticals raised a round of funding on November 04, 2011. Investors include Enisa.

3P Biopharmaceuticals is a European-based Contract Development and Manufacturing Organization (CDMO) specialized in the process development and GMP manufacture of biopharmaceutical and cell therapy pr…

Articles about 3P Biopharmaceuticals' Grant: